Intestinal microbiota influences clinical outcome and side effects of early breast cancer treatment/Experiment 2/Signature 2

From BugSigDB
Needs review

Curated date: 2024/04/20

Curator: Scholastica

Revision editor(s): Scholastica

Source: Fig. 1E

Description: Variable importance plot (VIP) scores obtained within partial least square discriminant analysis describing the most discriminant species in Post-CT TNM stage I (orange) compared to Post-CT TNM stage II-III (blue)

Abundance in Group 1: decreased abundance in Post-CT Stage II/III

NCBI Quality ControlLinks
Megamonas hypermegale
Slackia isoflavoniconvertens
Firmicutes bacterium CAG:110
Oscillibacter sp. CAG:241
Fusicatenibacter saccharivorans
Bacteroides faecis
Firmicutes bacterium CAG:95
[Ruminococcus] torques
Bacteroides cellulosilyticus
Agathobacter rectalis
Blautia obeum
Prevotella sp. CAG:755
Flavonifractor sp. An100
Victivallis vadensis
Clostridium disporicum
Prevotella sp. CAG:1185
Alistipes sp. An31A
Escherichia marmotae
Bacteroides sp. CAG:443
Actinomyces graevenitzii
Gemmiger formicilis
Phocaeicola vulgatus
Segatella copri
Haemophilus sp. HMSC71H05
Butyricimonas virosa
Lachnospira eligens
Odoribacter splanchnicus
Faecalibacterium prausnitzii
Desulfovibrio piger
Coprococcus comes
Coprococcus catus

Revision editor(s): Scholastica